MetLife Investment Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-877
Closed -$223K 2277
2020
Q3
$223K Hold
877
﹤0.01% 1800
2020
Q2
$148K Buy
+877
New +$148K ﹤0.01% 2064